Idexx Laboratories Stock Price Prediction
| IDXX Stock | USD 417.11 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Quarterly Earnings Growth 0.107 | EPS Estimate Next Quarter 2.52 | EPS Estimate Current Year 10.73 | EPS Estimate Next Year 11.8923 | Wall Street Target Price 478.6231 |
Using IDEXX Laboratories hype-based prediction, you can estimate the value of IDEXX Laboratories from the perspective of IDEXX Laboratories response to recently generated media hype and the effects of current headlines on its competitors.
IDEXX Laboratories Hype to Price Pattern
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of IDEXX Laboratories' market sentiment to its price can help taders to make decisions based on the overall investors consensus about IDEXX Laboratories.
The fear of missing out, i.e., FOMO, can cause potential investors in IDEXX Laboratories to buy its stock at a price that has no basis in reality. In that case, they are not buying IDEXX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
IDEXX Laboratories after-hype prediction price | USD 419.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
IDEXX |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IDEXX Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
IDEXX Laboratories After-Hype Price Prediction Density Analysis
As far as predicting the price of IDEXX Laboratories at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in IDEXX Laboratories or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of IDEXX Laboratories, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
IDEXX Laboratories Estimiated After-Hype Price Volatility
In the context of predicting IDEXX Laboratories' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on IDEXX Laboratories' historical news coverage. IDEXX Laboratories' after-hype downside and upside margins for the prediction period are 375.40 and 421.48, respectively. We have considered IDEXX Laboratories' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
IDEXX Laboratories is very steady at this time. Analysis and calculation of next after-hype price of IDEXX Laboratories is based on 3 months time horizon.
IDEXX Laboratories Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as IDEXX Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IDEXX Laboratories backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with IDEXX Laboratories, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 1.80 | 2.57 | 0.02 | 12 Events / Month | 5 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
417.11 | 419.68 | 0.62 |
|
IDEXX Laboratories Hype Timeline
IDEXX Laboratories is currently traded for 417.11. The entity has historical hype elasticity of 2.57, and average elasticity to hype of competition of -0.02. IDEXX is anticipated to increase in value after the next headline, with the price projected to jump to 419.68 or above. The average volatility of media hype impact on the company the price is about 21.05%. The price jump on the next news is projected to be 0.62%, whereas the daily expected return is currently at -0.3%. The volatility of related hype on IDEXX Laboratories is about 2172.41%, with the expected price after the next announcement by competition of 417.09. The company reported the previous year's revenue of 3.66 B. Net Income was 845.04 M with profit before overhead, payroll, taxes, and interest of 2 B. Given the investment horizon of 90 days the next anticipated press release will be in about 12 days. Check out IDEXX Laboratories Basic Forecasting Models to cross-verify your projections.IDEXX Laboratories Related Hype Analysis
Having access to credible news sources related to IDEXX Laboratories' direct competition is more important than ever and may enhance your ability to predict IDEXX Laboratories' future price movements. Getting to know how IDEXX Laboratories' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how IDEXX Laboratories may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CI | Cigna Corp | (0.51) | 10 per month | 0.00 | (0.18) | 2.06 | (3.76) | 12.85 | |
| DH | Definitive Healthcare Corp | (0.15) | 9 per month | 0.00 | (0.04) | 3.77 | (3.99) | 9.78 | |
| GH | Guardant Health | 2.26 | 10 per month | 2.50 | 0.13 | 7.53 | (4.35) | 20.17 | |
| LH | Laboratory of | 2.38 | 7 per month | 1.16 | (0.0003) | 1.99 | (1.91) | 7.89 | |
| MD | Mednax Inc | (0.22) | 7 per month | 1.58 | 0.12 | 3.63 | (3.02) | 27.59 | |
| DOCS | Doximity | (1.06) | 11 per month | 2.23 | 0.12 | 5.69 | (3.81) | 43.10 | |
| VEEV | Veeva Systems Class | (3.28) | 9 per month | 1.93 | 0.01 | 4.79 | (2.75) | 13.12 |
IDEXX Laboratories Additional Predictive Modules
Most predictive techniques to examine IDEXX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IDEXX using various technical indicators. When you analyze IDEXX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About IDEXX Laboratories Predictive Indicators
The successful prediction of IDEXX Laboratories stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as IDEXX Laboratories, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of IDEXX Laboratories based on analysis of IDEXX Laboratories hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to IDEXX Laboratories's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IDEXX Laboratories's related companies.
Story Coverage note for IDEXX Laboratories
The number of cover stories for IDEXX Laboratories depends on current market conditions and IDEXX Laboratories' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that IDEXX Laboratories is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about IDEXX Laboratories' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
IDEXX Laboratories Short Properties
IDEXX Laboratories' future price predictability will typically decrease when IDEXX Laboratories' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of IDEXX Laboratories often depends not only on the future outlook of the potential IDEXX Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IDEXX Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 84 M | |
| Cash And Short Term Investments | 453.9 M |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.